MARTEK BIOSCIENCES CORP Operating Cash Flow
MARTEK BIOSCIENCES CORP reported Operating Cash Flow of $146.02 million for the 12-month period ending 2010-10-31, per its 10-K filed 2010-12-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2010-12-29
- MARTEK BIOSCIENCES CORP net cash provided by (used in) operating activities for the quarter ending 2010-10-31 was $46.33M, a 79.43% increase year-over-year.
- MARTEK BIOSCIENCES CORP net cash provided by (used in) operating activities for the quarter ending 2009-10-31 was $25.82M.
- MARTEK BIOSCIENCES CORP net cash provided by (used in) operating activities for fiscal 2010 was $146.02M, a 121.84% increase from fiscal 2009.
- MARTEK BIOSCIENCES CORP net cash provided by (used in) operating activities for fiscal 2009 was $65.82M, a 38.22% decline from fiscal 2008.
- MARTEK BIOSCIENCES CORP net cash provided by (used in) operating activities for fiscal 2008 was $106.55M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|
| 2010-10-31 | $46.33M derived: 10-K 12 month − 10-Q 9 month · filed 2010-12-29 | $146.02M 10-K · filed 2010-12-29 | |
| 2010-07-31 | $99.69M 10-Q · filed 2010-09-08 | ||
| 2009-10-31 | $25.82M derived: 10-K 12 month − 10-Q 9 month · filed 2010-12-29 | $65.82M 10-K · filed 2010-12-29 | |
| 2009-07-31 | $40.00M 10-Q · filed 2010-09-08 | ||
| 2008-10-31 | $106.55M 10-K · filed 2010-12-29 |